Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Glucokinase Activator PB-201 and its Effects on the Glucose Excursion Profile in Drug-Naive Chinese Patients with Type 2 Diabetes: A Randomised Controlled, Crossover Trial

2021 ◽  
Author(s):  
Dongyang Liu ◽  
Ying Du ◽  
Xueting Yao ◽  
Yudong Wei ◽  
Jixiang Zhu ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Crossover Trial ◽  
Chinese Patients ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Glucose Excursion ◽  
Glucokinase Activator ◽  
Drug Naïve ◽  
Randomised Controlled

Safety, pharmacokinetics and pharmacodynamics of multiple-ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitus

2012 ◽  
Vol 14 (12) ◽  
pp. 1114-1122 ◽  
Author(s):  
L. A. Morrow ◽  
M. Leonsson-Zachrisson ◽  
H. Ericsson ◽  
M. Wollbratt ◽  
M. Knutsson ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
The Novel ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Glucokinase Activator

scholarly journals Effect of Linagliptin on Glycemic Control in Chinese Patients with Newly-Diagnosed, Drug-Naïve Type 2 Diabetes Mellitus: A Randomized Controlled Trial

2015 ◽  
Vol 21 ◽  
pp. 2678-2684 ◽  
Author(s):  
Wenjun Wu ◽  
Ying Li ◽  
Xiong Chen ◽  
Dini Lin ◽  
Songying Xiang ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Type 2 Diabetes Mellitus ◽  
Controlled Trial ◽  
Chinese Patients ◽  
Newly Diagnosed ◽  
Randomized Controlled ◽  
Drug Naïve
Sign in / Sign up

Export Citation Format

Share Document